1-6 of 6
Khee Chee Soo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical validation of breast cancer gene expression signatures using customized microarrays

Benita Tan, Lay Kar Tan, Kun Yu, Khee Chee Soo, Chow Yin Wong, Allen Yeo, Gay Hui Ho, Neng Hung Koong, Wei Sean Yong, Karen Yap, Puay Hoon Tan, Patrick B. Tan
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A81.
Published: 15 August 2014
View articletitled, Clinical validation of breast cancer gene expression signatures using customized microarrays
Journal Articles

Clinical validation of a customized multiple signature microarray for breast cancer

Lay Tan, Benita K T Tan, Kun Yu, Puay Hoon Tan, Khee Chee Soo, Patrick Boon Ooi Tan
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): C50.
Published: 15 August 2014
View articletitled, Clinical validation of a customized multiple signature microarray for breast cancer
Journal Articles

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

Hung Huynh, Van Chanh Ngo, Joseph Fargnoli, Mark Ayers, Khee Chee Soo, Heng Nung Koong, Choon Hua Thng, Hock Soo Ong, Alexander Chung, Pierce Chow, Pamela Pollock, Sara Byron, Evelyn Tran
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6146–6153.
https://doi.org/10.1158/1078-0432.CCR-08-0509
Published: 30 September 2008
View articletitled, Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Open the PDF for Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma in another window
Journal Articles

Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer

Benita K.T. Tan, Lay Keng Tan, Kun Yu, Puay Hoon Tan, Ming Lee, Lang Hiong Sii, Chow Yin Wong, Gay Hui Ho, Allen W.Y. Yeo, Pierce K.H. Chow, Heng Nung Koong, Wei Sean Yong, Dennis T.H. Lim, London L.P.J. Ooi, Khee Chee Soo, Patrick Tan
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 461–469.
https://doi.org/10.1158/1078-0432.CCR-07-0999
Published: 25 January 2008
View articletitled, Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer
Open the PDF for Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs

Hung Huynh, Khee Chee Soo, Pierce K.H. Chow, Lawrence Panasci, Evelyn Tran
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4306–4314.
https://doi.org/10.1158/1078-0432.CCR-05-2568
Published: 20 July 2006
View articletitled, Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs
Open the PDF for Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs in another window
Journal Articles

Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma

Min-Han Tan, Carl Morrison, Pengfei Wang, Ximing Yang, Carola J. Haven, Chun Zhang, Ping Zhao, Maria S. Tretiakova, Eeva Korpi-Hyovalti, John R. Burgess, Khee Chee Soo, Wei-Keat Cheah, Brian Cao, James Resau, Hans Morreau, Bin Tean Teh
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6629–6637.
https://doi.org/10.1158/1078-0432.CCR-04-0493
Published: 08 October 2004
View articletitled, Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma
Open the PDF for Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma in another window